me Posted May 29, 2007 24/05/2007 - The end of premature ejaculation is in sight as a simple inhalation of a drug promises to prolong the action under the sheets. UK pulmonary drug development company Vectura announced a potential breakthrough for the treatment of the strikingly common sexual dysfunction, which affects 30 per cent of men at some time in their life, after receiving successful results in its Phase IIa proof-of-concept clinical study. By simply inhaling Vectura's product VR776, patients demonstrated a clinical effect within 15 minutes of dosing and an improvement in the time it took for ejaculation within the vagina, known as intravaginal ejaculatory latency time (IVELT). Not only is this exciting news for the some 50 million men affected in Europe and the US who have no approved product to turn to, but the novel system by which the drug is delivered, means the drug taking does not have to occur six hours before a naughty rendezvous, which would be the case if the treatment was in pill form. By using Vectura's Aspirair dry powder inhaler (DPI), a patent-protected single unit dose DPI, VR776 can be delivered with a high lung penetration and rapid delivery to the bloodstream. Vectura believed the device was conveniently sized and simple to use compared to other inhalers. The inhaler works by generating an aerosol plume, triggered by a patient's inhalation, which is slower than most spray type active inhalers currently available. This means that the amount of powder that is unintentionally deposited in the mouth and throat is reduced. VR776, a proprietary formulation of a centrally-acting undisclosed drug which works in the brain to delay ejaculation, is formulated using PowderHale, a patented technology optimising the delivery of dry powders. Typically, dry powder inhaled formulations have a limited penetration to the lungs, but PowderHale delivers a consistent fine particle dose of the drug to the lung with a high penetration by modifying the interactive forces holding together the active drug particle and carrier particles. "We are very pleased to have achieved proof of concept and demonstrated the VR766 improves IVELT," Vectura director of investor relations and corporate communications Julia Wilson told in-PharmaTechnologist.com. Clinically, PE is defined as a persistent or recurrent ejaculation occurring sooner than desired either before or shortly after penetration, typically in less than two minutes, over which the sufferer has minimal or no control. Current treatment is counselling and/or the use of desensitising products. Wilson said that while the product still needed further refinement, VR776 had "a huge market potential". Vectura chief executive Dr Chris Blackwell said: "Premature ejaculation is a common and distinct medical condition that can severely impact quality of life, affecting the physical and emotional well-being of patients and their partners. "The initial evaluation of the results of this study endorses our belief that the potential remains for VR776 to be a rapidly-acting and effective treatment for PE patients. We are also very pleased that the study provides further validation of the effectiveness of our Aspirair dry powder inhaler device," he said. Vectura believed the next stage in the development of VR776 was to establish whether bigger improvements in IVELT could be achieved at higher doses to optimise the potential therapeutic benefit, and may require reformulation of the product. Vectura is also developing VR004, an inhaled systemic product for treating erectile dysfunction. Successful Phase IIb clinical trials have been completed and Vectura is now seeking licensing partners for the product. Earlier today, UK-based urological disorder product development and marketing company Plethora Solutions announced it had signed an exclusive license agreement with US pharmaceutical company Sciele Pharma for the marketing of PSD502 for premature ejaculation in the US. PSD502 comprises a unique, proprietary, and rapidly absorbed formulation of two well-established anaesthetics, lidocaine and prilocaine, dispensed in a metered-dose spray. Plethora has completed a Phase II clinical trial using PSD502, and Plethora is expected to begin a Phase III study in the second half of 2007. Quote Share this post Link to post Share on other sites
Centurion Posted May 29, 2007 typical British journalism Inhaler solution to premature ejaculation hasn't come too soon Quote Share this post Link to post Share on other sites
Sophist Posted May 29, 2007 Recommend it be used in conjunction with the famous "Hymen Eliminator", as a package deal from Eros Inc! Quote Share this post Link to post Share on other sites
Zafir Posted May 29, 2007 ^I don't get it, what's Hymen Eliminator? Quote Share this post Link to post Share on other sites
me Posted May 29, 2007 So no premature ejaculators here? I see all ya'll tip toeing around the subject. Quote Share this post Link to post Share on other sites
-Lily- Posted May 29, 2007 Praise the Lord that a woman will never be ‘unable to function’... Quote Share this post Link to post Share on other sites
Ms DD Posted May 29, 2007 Get with the programme Lily . Menapause / hot flushes comes to mind. Quote Share this post Link to post Share on other sites
-Lily- Posted May 29, 2007 I have never heard of menopause stopping women from performing? That's just like being unwell isn't it? (I’ve just checked the NHS health encyclopaedia and nothing that states that menopause has any influence on sex.) Quote Share this post Link to post Share on other sites
Ms DD Posted May 29, 2007 I heard ..haweenka ma jecla in loo soo dhawaado. Quote Share this post Link to post Share on other sites
Intuition Posted May 29, 2007 lol @ Me I noticed the tip toeing as well. So which one of you blokes are gonna admit to being involved in the Study? Quote Share this post Link to post Share on other sites
me Posted May 29, 2007 So females, whats your opinion on premature ejaculators? I read there are two kinds of women, the kind that get angry and the kind that comfort their men, which one would you be? Quote Share this post Link to post Share on other sites
Intuition Posted May 29, 2007 Ms DD they probably get innoyed and have mood swings, but technically I guess they can still do the deed. Most women get the symptoms of menopause treated so they can continue living very healthy lives. I could be considered an advantage...no unexpected pregnancy. Quote Share this post Link to post Share on other sites
Intuition Posted May 29, 2007 LoooL Me, That was a very unexpected question. I don't know how I would react since I ain’t married so I’m not exactly sure on what I’m missing out on yet. But I think the important thing is that he has to be able to function on some level, and the condition should be treated ASAP (for his comfort and feelings of course) I mean I hope to be the caring supportive wife who will comfort her man in his time of need. But at the end of the day all problems must be fixed, or else yelling will commence. Or product will be replaced. Quote Share this post Link to post Share on other sites
me Posted May 29, 2007 ^ how loving and caring of you. Any other brave souls? Quote Share this post Link to post Share on other sites
Valenteenah. Posted May 29, 2007 Originally posted by Zafir: ^I don't get it, what's Hymen Eliminator? Guessing a fancy name for the male genital? Quote Share this post Link to post Share on other sites